Janone to present in person and by video at h.c. wainwright's 25th annual global investment conference

Chief medical officer dr. amol soin will discuss innovative approaches to pain management and janone's development of non-addicting treatments for pain las vegas , aug. 31, 2023 /prnewswire/ -- janone (nasdaq: jan), the biopharmaceutical company focused on developing non-addicting painkillers and novel treatments for the causes of pain, will participate in investor sessions at the h.c. wainwright 25 th  annual global investment conference in new york city.
JAN Ratings Summary
JAN Quant Ranking